PCM
AURA icon

Permanent Capital Management’s Aura Biosciences AURA Stock Holding History

Permanent Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$440K Sell
62,369
-13,495
-18% -$77.4K 0.07% 84
2025
Q4 		$413K Sell
75,864
-71,905
-49% -$427K 0.08% 91
2025
Q3 		$913K Buy
+147,769
New +$966K 0.17% 58
2024
Q2 		$903K Buy
+144,229
New +$1.06M 0.19% 56

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Permanent Capital Management's AURA Position: Q1 2026 in Review

Permanent Capital Management reduced its Aura Biosciences (AURA) stake by 18% in Q1 2026, selling an estimated $77.4K and leaving 62,369 shares worth $440K. The position accounts for 0.07% of the portfolio, ranked #84.

Permanent Capital Management first reported a position in AURA in Q2 2024 and has held it in 4 quarters since. The position peaked at $913K in Q3 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Permanent Capital Management held 62,369 shares of Aura Biosciences worth $440K as of Q1 2026.
  • Permanent Capital Management sold 13,495 Aura Biosciences shares in Q1 2026, an estimated $77.4K.
  • Aura Biosciences made up 0.07% of Permanent Capital Management's portfolio in Q1 2026, its #84 holding.
  • Permanent Capital Management first reported a position in Aura Biosciences in Q2 2024 and has held it in 4 quarters since.
  • Permanent Capital Management's Aura Biosciences position peaked at $913K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Permanent Capital Management's 13F filing for Q1 2026, filed 14 May 2026.